HOME >> MEDICINE >> NEWS
Long-term data show benefit of DETROL LA as first-line therapy for overactive bladder

isodes associated with overactive bladder.

Since its introduction in January 2001, DETROL LA has become the number one prescribed treatment for overactive bladder in the United States and has been prescribed for more than seven million patients worldwide.

DETROL LA is indicated for the treatment of overactive bladder with symptoms of urge incontinence, urgency and frequency.

DETROL LA is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma and in patients who have demonstrated hypersensitivity to the drug or its ingredients.

Patients with the following conditions should be treated with caution: renal impairment, bladder outflow obstruction, gastrointestinal obstructive disorders, controlled narrow-angle glaucoma, and significantly reduced hepatic function. Dry mouth was the most frequently reported adverse event (DETROL LA 23 percent vs. placebo 8 percent); others (> 4 percent) included headache (DETROL LA 6 percent vs. placebo 4 percent), constipation (DETROL LA 6 percent vs. placebo 4 percent), and abdominal pain (DETROL LA 4 percent vs. placebo 2 percent).


'"/>


13-Dec-2004


Page: 1 2 3

Related medicine news :

1. Long-term high consumption of red and processed meat linked with increased risk for colon cancer
2. Long-term benefits for newly diagnosed patients with CML receiving first-line therapy with imatinib
3. Long-term obesity linked to loss of brain tissue in women
4. Long-term study demonstrated ADDERALL XR is an effective option to treat adolescents with ADHA
5. Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD
6. Long-term use of antibiotics possibly linked with increased risk of breast cancer
7. Long-term follow-up of mortality in patients with community-acquired pneumonia
8. Long-term outcome of epilepsy surgery is favorable for many
9. Long-term ERT in postmenopausal women with Alzheimers may worsen memory
10. Long-term avoidance of milk in children results in poor bone health
11. Long-term effects of tirofiban similar to abciximab in patients having coronary-artery angioplasty

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... May 31, 2016 , ... St. Joseph ... regional health information exchange, which enables physicians at SJMC’s two hospital campuses, downtown ... other participating organizations in the exchange. SJMC’s membership in the health information exchange ...
(Date:5/31/2016)... Park, Maryland (PRWEB) , ... May 31, 2016 ... ... ability to attribute calls back to particular advertising campaigns, to monitor the performance ... so that they can maximize conversions and revenue. The software allows customers to ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Global Wellness Summit ... ten predictions on the future of wellness, travel, spa and beauty in Europe. The ... and beauty companies to leading economists and researchers - to forecast where wellness is ...
(Date:5/31/2016)... Yorba Linda, CA (PRWEB) , ... May 31, 2016 , ... ... as both a primary screening tool and as an orthogonal tool for RNAi hit ... selects highly functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections ...
(Date:5/31/2016)... ... May 31, 2016 , ... Dr. Charles A. Ditta attained his Doctor of ... the class of 1986, where he graduated in the top ten percentile of his ... Livingston since 1989. He has been a member in good standing for thirty years ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 2016 LabStyle Innovations Corp . ... Tool, today announced that the Company,s Chief Financial Officer, ... being held June 1-2 in New York, NY ... 7-9 in Los Angeles, CA. ... and operational milestones, including the U.S. FDA Clearance and commercial ...
(Date:5/27/2016)... , May 27, 2016 ... drug manufacturers, health insurance companies all falling under its ... healthcare companies. While not often talked about, these healthcare ... The United States is by far the ... Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: ...
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology:
Cached News: